Want to join the conversation?
In the US, $MCD's 1Q16 pricing was up over 3% YoverY. For the International Lead segment, YoverY price increases averaged 2-3%. In the US, commodity costs were down 3% and are expected to decline 3.5-4.5% for the year. For International Lead, commodity costs were relatively flat for 1Q16 and are expected to remain relatively flat for the year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?